KPCG_MOUSE
ID KPCG_MOUSE Reviewed; 697 AA.
AC P63318; P05697;
DT 11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT 11-OCT-2004, sequence version 1.
DT 03-AUG-2022, entry version 168.
DE RecName: Full=Protein kinase C gamma type;
DE Short=PKC-gamma;
DE EC=2.7.11.13;
GN Name=Prkcg; Synonyms=Pkcc, Pkcg, Prkcc;
OS Mus musculus (Mouse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Mus; Mus.
OX NCBI_TaxID=10090;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Brain;
RX PubMed=8428669; DOI=10.1016/0378-1119(93)90135-p;
RA Bowers B.J., Parham C.L., Sikela J.M., Wehner J.M.;
RT "Isolation and sequence of a mouse brain cDNA coding for protein kinase C-
RT gamma isozyme.";
RL Gene 123:263-265(1993).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC STRAIN=BALB/cJ; TISSUE=Brain;
RA Tseng C.P., Verma A.;
RL Submitted (JAN-1994) to the EMBL/GenBank/DDBJ databases.
RN [3]
RP FUNCTION IN LONG-TERM POTENTIATION.
RX PubMed=8269509; DOI=10.1016/0092-8674(93)90613-u;
RA Abeliovich A., Chen C., Goda Y., Silva A.J., Stevens C.F., Tonegawa S.;
RT "Modified hippocampal long-term potentiation in PKC gamma-mutant mice.";
RL Cell 75:1253-1262(1993).
RN [4]
RP DISRUPTION PHENOTYPE.
RX PubMed=8548809; DOI=10.1016/0092-8674(95)90148-5;
RA Chen C., Kano M., Abeliovich A., Chen L., Bao S., Kim J.J., Hashimoto K.,
RA Thompson R.F., Tonegawa S.;
RT "Impaired motor coordination correlates with persistent multiple climbing
RT fiber innervation in PKC gamma mutant mice.";
RL Cell 83:1233-1242(1995).
RN [5]
RP FUNCTION IN NEUROPATHIC PAIN.
RX PubMed=9323205; DOI=10.1126/science.278.5336.279;
RA Malmberg A.B., Chen C., Tonegawa S., Basbaum A.I.;
RT "Preserved acute pain and reduced neuropathic pain in mice lacking
RT PKCgamma.";
RL Science 278:279-283(1997).
RN [6]
RP FUNCTION IN OPIOID SIGNALING.
RX PubMed=11278552; DOI=10.1074/jbc.m009716200;
RA Narita M., Mizoguchi H., Suzuki T., Narita M., Dun N.J., Imai S.,
RA Yajima Y., Nagase H., Suzuki T., Tseng L.F.;
RT "Enhanced mu-opioid responses in the spinal cord of mice lacking protein
RT kinase Cgamma isoform.";
RL J. Biol. Chem. 276:15409-15414(2001).
RN [7]
RP FUNCTION IN OPIOID SIGNALING.
RX PubMed=11356858; DOI=10.1523/jneurosci.21-11-03715.2001;
RA Narita M., Mizoguchi H., Narita M., Nagase H., Suzuki T., Tseng L.F.;
RT "Involvement of spinal protein kinase Cgamma in the attenuation of opioid
RT mu-receptor-mediated G-protein activation after chronic intrathecal
RT administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.";
RL J. Neurosci. 21:3715-3720(2001).
RN [8]
RP FUNCTION IN OPIOID SIGNALING.
RX PubMed=11246146; DOI=10.1016/s0306-4522(00)00572-8;
RA Narita M., Aoki T., Ozaki S., Yajima Y., Suzuki T.;
RT "Involvement of protein kinase Cgamma isoform in morphine-induced
RT reinforcing effects.";
RL Neuroscience 103:309-314(2001).
RN [9]
RP FUNCTION IN OPIOID SIGNALING.
RX PubMed=11731061; DOI=10.1016/s0304-3959(01)00353-0;
RA Zeitz K.P., Malmberg A.B., Gilbert H., Basbaum A.I.;
RT "Reduced development of tolerance to the analgesic effects of morphine and
RT clonidine in PKC gamma mutant mice.";
RL Pain 94:245-253(2001).
RN [10]
RP PHOSPHORYLATION AT THR-514; THR-655 AND THR-674, SUBCELLULAR LOCATION,
RP FUNCTION, AND TISSUE SPECIFICITY.
RX PubMed=17904530; DOI=10.1016/j.bbrc.2007.09.062;
RA Ikeda A., Miyazaki T., Kakizawa S., Okuno Y., Tsuchiya S., Myomoto A.,
RA Saito S.Y., Yamamoto T., Yamazaki T., Iino M., Tsujimoto G., Watanabe M.,
RA Takeshima H.;
RT "Abnormal features in mutant cerebellar Purkinje cells lacking
RT junctophilins.";
RL Biochem. Biophys. Res. Commun. 363:835-839(2007).
RN [11]
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Brain cortex;
RX PubMed=17114649; DOI=10.1074/mcp.m600046-mcp200;
RA Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,
RA Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., Gerrits B.,
RA Panse C., Schlapbach R., Mansuy I.M.;
RT "Qualitative and quantitative analyses of protein phosphorylation in naive
RT and stimulated mouse synaptosomal preparations.";
RL Mol. Cell. Proteomics 6:283-293(2007).
RN [12]
RP SUBCELLULAR LOCATION.
RX PubMed=18473171; DOI=10.1007/s11064-008-9727-4;
RA Matsumoto S., Murozono M., Nagaoka D., Matsuoka S., Takeda A., Narita H.,
RA Watanabe S., Isshiki A., Watanabe Y.;
RT "Isoflurane inhibits protein kinase Cgamma and calcium/calmodulin dependent
RT protein kinase ii-alpha translocation to synaptic membranes in ischemic
RT mice brains.";
RL Neurochem. Res. 33:2302-2309(2008).
RN [13]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320; SER-322; SER-326;
RP SER-328; SER-330; THR-332 AND SER-373, AND IDENTIFICATION BY MASS
RP SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Brain;
RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL Cell 143:1174-1189(2010).
RN [14]
RP FUNCTION, INTERACTION WITH ARNTL, DISRUPTION PHENOTYPE, TISSUE SPECIFICITY,
RP AND PHOSPHORYLATION AT THR-655.
RX PubMed=23185022; DOI=10.1073/pnas.1218699110;
RA Zhang L., Abraham D., Lin S.T., Oster H., Eichele G., Fu Y.H., Ptacek L.J.;
RT "PKCgamma participates in food entrainment by regulating BMAL1.";
RL Proc. Natl. Acad. Sci. U.S.A. 109:20679-20684(2012).
CC -!- FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-
CC dependent serine/threonine-protein kinase that plays diverse roles in
CC neuronal cells and eye tissues, such as regulation of the neuronal
CC receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and
CC neuronal functions related to sensitivity to opiates, pain and alcohol,
CC mediation of synaptic function and cell survival after ischemia, and
CC inhibition of gap junction activity after oxidative stress. Binds and
CC phosphorylates GRIA4/GLUR4 glutamate receptor and regulates its
CC function by increasing plasma membrane-associated GRIA4 expression. In
CC primary cerebellar neurons treated with the agonist 3,5-
CC dihyidroxyphenylglycine, functions downstream of the metabotropic
CC glutamate receptor GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor
CC which plays a key role in synaptic plasticity, synaptogenesis,
CC excitotoxicity, memory acquisition and learning. May be involved in the
CC regulation of hippocampal long-term potentiation (LTP), but may be not
CC necessary for the process of synaptic plasticity. May be involved in
CC desensitization of mu-type opioid receptor-mediated G-protein
CC activation in the spinal cord, and may be critical for the development
CC and/or maintenance of morphine-induced reinforcing effects in the
CC limbic forebrain. May modulate the functionality of mu-type-opioid
CC receptors by participating in a signaling pathway which leads to the
CC phosphorylation and degradation of opioid receptors. May also
CC contribute to chronic morphine-induced changes in nociceptive
CC processing. Plays a role in neuropathic pain mechanisms and contributes
CC to the maintenance of the allodynia pain produced by peripheral
CC inflammation. Plays an important role in initial sensitivity and
CC tolerance to ethanol, by mediating the behavioral effects of ethanol as
CC well as the effects of this drug on the GABA(A) receptors. During and
CC after cerebral ischemia modulate neurotransmission and cell survival in
CC synaptic membranes, and is involved in insulin-induced inhibition of
CC necrosis, an important mechanism for minimizing ischemic injury.
CC Required for the elimination of multiple climbing fibers during
CC innervation of Purkinje cells in developing cerebellum. Is activated in
CC lens epithelial cells upon hydrogen peroxide treatment, and
CC phosphorylates connexin-43 (GJA1/CX43), resulting in disassembly of
CC GJA1 gap junction plaques and inhibition of gap junction activity which
CC could provide a protective effect against oxidative stress.
CC Phosphorylates p53/TP53 and promotes p53/TP53-dependent apoptosis in
CC response to DNA damage. Involved in the phase resetting of the cerebral
CC cortex circadian clock during temporally restricted feeding. Stabilizes
CC the core clock component ARNTL/BMAL1 by interfering with its
CC ubiquitination, thus suppressing its degradation, resulting in phase
CC resetting of the cerebral cortex clock (PubMed:23185022).
CC {ECO:0000269|PubMed:11246146, ECO:0000269|PubMed:11278552,
CC ECO:0000269|PubMed:11356858, ECO:0000269|PubMed:11731061,
CC ECO:0000269|PubMed:17904530, ECO:0000269|PubMed:23185022,
CC ECO:0000269|PubMed:8269509, ECO:0000269|PubMed:9323205}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC EC=2.7.11.13;
CC -!- COFACTOR:
CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC Evidence={ECO:0000255|PROSITE-ProRule:PRU00041};
CC Note=Binds 3 Ca(2+) ions per subunit. The ions are bound to the C2
CC domain. {ECO:0000250|UniProtKB:P05129};
CC -!- ACTIVITY REGULATION: Classical (or conventional) PKCs (PRKCA, PRKCB and
CC PRKCG) are activated by calcium and diacylglycerol (DAG) in the
CC presence of phosphatidylserine. Three specific sites; Thr-514
CC (activation loop of the kinase domain), Thr-655 (turn motif) and Thr-
CC 674 (hydrophobic region), need to be phosphorylated for its full
CC activation.
CC -!- SUBUNIT: Interacts with CDCP1 and GRIA4 (By similarity). Interacts with
CC TP53INP1 and p53/TP53 (By similarity). Interacts with ARNTL/BMAL1.
CC {ECO:0000250|UniProtKB:P05129, ECO:0000250|UniProtKB:P63319,
CC ECO:0000269|PubMed:23185022}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17904530}.
CC Cytoplasm, perinuclear region {ECO:0000250}. Cell membrane
CC {ECO:0000269|PubMed:17904530, ECO:0000269|PubMed:18473171}; Peripheral
CC membrane protein. Synapse, synaptosome {ECO:0000269|PubMed:18473171}.
CC Cell projection, dendrite {ECO:0000250|UniProtKB:P63319}.
CC Note=Translocates to synaptic membranes on stimulation.
CC {ECO:0000269|PubMed:18473171}.
CC -!- TISSUE SPECIFICITY: Expressed in the cerebellum, cerebral cortex and
CC hippocampus (at protein level). Highly expressed in Purkinje cells.
CC {ECO:0000269|PubMed:17904530, ECO:0000269|PubMed:23185022}.
CC -!- PTM: Autophosphorylation on Thr-674 appears to regulate motor functions
CC of junctophilins, JPH3 and JPH4. {ECO:0000269|PubMed:17904530}.
CC -!- PTM: Ubiquitinated. {ECO:0000250|UniProtKB:P05129}.
CC -!- DISRUPTION PHENOTYPE: Mice exhibit impaired motor coordination due to
CC the inability to eliminate multiple climbing fibers during innervation
CC of Purkinje cells. 40% of Purkinje cells are still innervated by
CC multiple climbing fibers. Exhibit food-anticipatory activity comparable
CC to that of wild type mice but they do not reduce their late night
CC activity or adapt their food intake amount to restricted feeding as
CC efficiently as wild type mice. {ECO:0000269|PubMed:23185022,
CC ECO:0000269|PubMed:8548809}.
CC -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC protein kinase family. PKC subfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; X67129; CAA47608.1; -; mRNA.
DR EMBL; L28035; AAA39939.1; -; mRNA.
DR CCDS; CCDS57470.1; -.
DR PIR; JN0548; JN0548.
DR RefSeq; NP_035232.1; NM_011102.4.
DR AlphaFoldDB; P63318; -.
DR SMR; P63318; -.
DR BioGRID; 202196; 31.
DR IntAct; P63318; 20.
DR MINT; P63318; -.
DR STRING; 10090.ENSMUSP00000097874; -.
DR iPTMnet; P63318; -.
DR PhosphoSitePlus; P63318; -.
DR SwissPalm; P63318; -.
DR jPOST; P63318; -.
DR PaxDb; P63318; -.
DR PeptideAtlas; P63318; -.
DR PRIDE; P63318; -.
DR ProteomicsDB; 264862; -.
DR Antibodypedia; 32756; 672 antibodies from 39 providers.
DR DNASU; 18752; -.
DR Ensembl; ENSMUST00000100301; ENSMUSP00000097874; ENSMUSG00000078816.
DR GeneID; 18752; -.
DR KEGG; mmu:18752; -.
DR UCSC; uc029wcz.2; mouse.
DR CTD; 5582; -.
DR MGI; MGI:97597; Prkcg.
DR VEuPathDB; HostDB:ENSMUSG00000078816; -.
DR eggNOG; KOG0696; Eukaryota.
DR GeneTree; ENSGT00940000161219; -.
DR InParanoid; P63318; -.
DR OMA; DLKSQHT; -.
DR OrthoDB; 614710at2759; -.
DR PhylomeDB; P63318; -.
DR TreeFam; TF351133; -.
DR BRENDA; 2.7.11.13; 3474.
DR Reactome; R-MMU-111933; Calmodulin induced events.
DR Reactome; R-MMU-114516; Disinhibition of SNARE formation.
DR Reactome; R-MMU-416993; Trafficking of GluR2-containing AMPA receptors.
DR Reactome; R-MMU-5099900; WNT5A-dependent internalization of FZD4.
DR Reactome; R-MMU-76005; Response to elevated platelet cytosolic Ca2+.
DR BioGRID-ORCS; 18752; 0 hits in 110 CRISPR screens.
DR PRO; PR:P63318; -.
DR Proteomes; UP000000589; Chromosome 7.
DR RNAct; P63318; protein.
DR Bgee; ENSMUSG00000078816; Expressed in Ammon's horn and 57 other tissues.
DR ExpressionAtlas; P63318; baseline and differential.
DR Genevisible; P63318; MM.
DR GO; GO:0044305; C:calyx of Held; IDA:SynGO.
DR GO; GO:0005911; C:cell-cell junction; IDA:MGI.
DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR GO; GO:0030425; C:dendrite; IDA:MGI.
DR GO; GO:0016020; C:membrane; ISO:MGI.
DR GO; GO:0043005; C:neuron projection; ISO:MGI.
DR GO; GO:0005634; C:nucleus; IDA:MGI.
DR GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR GO; GO:0099524; C:postsynaptic cytosol; ISO:MGI.
DR GO; GO:0014069; C:postsynaptic density; IDA:MGI.
DR GO; GO:0099523; C:presynaptic cytosol; IDA:SynGO.
DR GO; GO:0097060; C:synaptic membrane; IDA:UniProtKB.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0004698; F:calcium-dependent protein kinase C activity; ISO:MGI.
DR GO; GO:0004672; F:protein kinase activity; ISO:MGI.
DR GO; GO:0004697; F:protein kinase C activity; ISO:MGI.
DR GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; ISO:MGI.
DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR GO; GO:0007268; P:chemical synaptic transmission; IMP:UniProtKB.
DR GO; GO:0007635; P:chemosensory behavior; IMP:MGI.
DR GO; GO:0060384; P:innervation; IMP:UniProtKB.
DR GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR GO; GO:0060291; P:long-term synaptic potentiation; ISO:MGI.
DR GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR GO; GO:1901799; P:negative regulation of proteasomal protein catabolic process; IMP:UniProtKB.
DR GO; GO:0042177; P:negative regulation of protein catabolic process; ISO:MGI.
DR GO; GO:0031397; P:negative regulation of protein ubiquitination; IMP:UniProtKB.
DR GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR GO; GO:0016310; P:phosphorylation; ISO:MGI.
DR GO; GO:0032425; P:positive regulation of mismatch repair; ISO:MGI.
DR GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR GO; GO:0046777; P:protein autophosphorylation; ISO:MGI.
DR GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
DR GO; GO:0050764; P:regulation of phagocytosis; IMP:MGI.
DR GO; GO:0032095; P:regulation of response to food; IMP:UniProtKB.
DR GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IDA:SynGO.
DR GO; GO:0043278; P:response to morphine; IMP:UniProtKB.
DR GO; GO:0048265; P:response to pain; IMP:UniProtKB.
DR GO; GO:1990911; P:response to psychosocial stress; ISO:MGI.
DR GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR CDD; cd00029; C1; 2.
DR Gene3D; 2.60.40.150; -; 1.
DR InterPro; IPR000961; AGC-kinase_C.
DR InterPro; IPR046349; C1-like_sf.
DR InterPro; IPR000008; C2_dom.
DR InterPro; IPR035892; C2_domain_sf.
DR InterPro; IPR020454; DAG/PE-bd.
DR InterPro; IPR011009; Kinase-like_dom_sf.
DR InterPro; IPR002219; PE/DAG-bd.
DR InterPro; IPR017892; Pkinase_C.
DR InterPro; IPR000719; Prot_kinase_dom.
DR InterPro; IPR017441; Protein_kinase_ATP_BS.
DR InterPro; IPR014375; Protein_kinase_C_a/b/g.
DR InterPro; IPR008271; Ser/Thr_kinase_AS.
DR Pfam; PF00130; C1_1; 2.
DR Pfam; PF00168; C2; 1.
DR Pfam; PF00069; Pkinase; 1.
DR Pfam; PF00433; Pkinase_C; 1.
DR PIRSF; PIRSF000550; PKC_alpha; 1.
DR PRINTS; PR00360; C2DOMAIN.
DR PRINTS; PR00008; DAGPEDOMAIN.
DR SMART; SM00109; C1; 2.
DR SMART; SM00239; C2; 1.
DR SMART; SM00133; S_TK_X; 1.
DR SMART; SM00220; S_TKc; 1.
DR SUPFAM; SSF49562; SSF49562; 1.
DR SUPFAM; SSF56112; SSF56112; 1.
DR SUPFAM; SSF57889; SSF57889; 2.
DR PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR PROSITE; PS50004; C2; 1.
DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE 1: Evidence at protein level;
KW ATP-binding; Biological rhythms; Calcium; Cell membrane; Cell projection;
KW Cytoplasm; Kinase; Membrane; Metal-binding; Nucleotide-binding;
KW Phosphoprotein; Reference proteome; Repeat;
KW Serine/threonine-protein kinase; Synapse; Synaptosome; Transferase;
KW Ubl conjugation; Zinc; Zinc-finger.
FT CHAIN 1..697
FT /note="Protein kinase C gamma type"
FT /id="PRO_0000055690"
FT DOMAIN 157..275
FT /note="C2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT DOMAIN 351..614
FT /note="Protein kinase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT DOMAIN 615..685
FT /note="AGC-kinase C-terminal"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT ZN_FING 35..85
FT /note="Phorbol-ester/DAG-type 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT ZN_FING 100..150
FT /note="Phorbol-ester/DAG-type 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT ACT_SITE 480
FT /note="Proton acceptor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT ECO:0000255|PROSITE-ProRule:PRU10027"
FT BINDING 186
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="1"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 187
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="1"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 187
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="2"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 193
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="2"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 246
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="1"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 246
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="2"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 247
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="2"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 248
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="1"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 248
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="2"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 248
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="3"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 251
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="3"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 252
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="3"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 254
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="1"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 254
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /ligand_label="3"
FT /evidence="ECO:0000250|UniProtKB:P05129"
FT BINDING 357..365
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT BINDING 380
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT MOD_RES 250
FT /note="Phosphothreonine; by autocatalysis"
FT /evidence="ECO:0000250"
FT MOD_RES 320
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:21183079"
FT MOD_RES 322
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:21183079"
FT MOD_RES 326
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:21183079"
FT MOD_RES 328
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:21183079"
FT MOD_RES 330
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:21183079"
FT MOD_RES 332
FT /note="Phosphothreonine"
FT /evidence="ECO:0007744|PubMed:21183079"
FT MOD_RES 373
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:21183079"
FT MOD_RES 514
FT /note="Phosphothreonine; by PDPK1"
FT /evidence="ECO:0000305|PubMed:17904530"
FT MOD_RES 648
FT /note="Phosphothreonine; by autocatalysis"
FT /evidence="ECO:0000255"
FT MOD_RES 655
FT /note="Phosphothreonine; by autocatalysis"
FT /evidence="ECO:0000269|PubMed:17904530,
FT ECO:0000269|PubMed:23185022"
FT MOD_RES 674
FT /note="Phosphothreonine; by autocatalysis"
FT /evidence="ECO:0000269|PubMed:17904530"
FT MOD_RES 675
FT /note="Phosphotyrosine; by SYK"
FT /evidence="ECO:0000250"
FT MOD_RES 687
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:P63319"
SQ SEQUENCE 697 AA; 78358 MW; E6E2F7A3B93042FF CRC64;
MAGLGPGGGD SEGGPRPLFC RKGALRQKVV HEVKSHKFTA RFFKQPTFCS HCTDFIWGIG
KQGLQCQVCS FVVHRRCHEF VTFECPGAGK GPQTDDPRNK HKFRLHSYSS PTFCDHCGSL
LYGLVHQGMK CSCCEMNVHR RCVRSVPSLC GVDHTERRGR LQLEIRAPTS DEIHITVGEA
RNLIPMDPNG LSDPYVKLKL IPDPRNLTKQ KTKTVKATLN PVWNETFVFN LKPGDVERRL
SVEVWDWDRT SRNDFMGAMS FGVSELLKAP VDGWYKLLNQ EEGEYYNVPV ADADNCSLLQ
KFEACNYPLE LYERVRMGPS SSPIPSPSPS PTDSKRCFFG ASPGRLHISD FSFLMVLGKG
SFGKVMLAER RGSDELYAIK ILKKDVIVQD DDVDCTLVEK RVLALGGRGP GGRPHFLTQL
HSTFQTPDRL YFVMEYVTGG DLMYHIQQLG KFKEPHAAFY AAEIAIGLFF LHNQGIIYRD
LKLDNVMLDA EGHIKITDFG MCKENVFPGS TTRTFCGTPD YIAPEIIAYQ PYGKSVDWWS
FGVLLYEMLA GQPPFDGEDE EELFQAIMEQ TVTYPKSLSR EAVAICKGFL TKHPGKRLGS
GPDGEPTIRA HGFFRWIDWE RLERLEIAPP FRPRPCGRSG ENFDKFFTRA APALTPPDRL
VLASIDQADF QGFTYVNPDF VHPDARSPTS PVPVPVM
